🔎 Trials Near Me

Nyumbani › Uzito Kupita Kiasi › Texas › Austin

Majaribio ya kliniki ya Uzito Kupita Kiasi katika Austin, TX

Masomo 18 ya Uzito Kupita Kiasi yanatafuta washiriki katika vituo vya Austin na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

InaajiriHatua 2
  • Elligo Clinical Research Center /ID# 282166, Austin
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

InaajiriHatua 3
  • Texas Diabetes & Endocrinology, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

InaajiriHatua 3
  • IMA Clinical Research Austin, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

InaajiriHatua 3
  • Dell Children's Medical Center - PIN, Austin
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

InaajiriHatua 3
  • IMA Clinical Research Austin, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

InaajiriHatua 3
  • FutureSearch Trials of Neurology, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

InaajiriHatua 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Umri 45 hadi 99 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • IMA Clinical Research Austin, Austin
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
  • The University of Texas at Austin, Austin
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

InaajiriHatua 3
  • AURORA-1 Clinical Site, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

InaajiriHatua 3
  • AURORA-2 Clinical Site, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
  • ACCOMPLISH-2 Research Site, Austin
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • IMA Clinical Research Austin, Austin
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

InaajiriHatua 3
  • Elligo Clinical Research Center, Austin
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

InaajiriHatua 3
  • Elligo Clinical Research Center, Austin
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

InaajiriHatua 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

InaajiriHatua 1
  • Elligo Clin Res Centre, Austin
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Jun 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

InaajiriHatua 1
  • Corxel Investigational Site, Austin
Umri 18 hadi 55 · Wanawake · Imesasishwa 17 Jun 2026 · NCT07652047

Majaribio ya Uzito Kupita Kiasi katika miji mingine

Masomo mengine katika Austin

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.